Pediatric Onset Multiple Sclerosis: Updates on Treatment Options

Presented by

Kaitlyn Cartwright, MD

Assistant Professor of Neurology

Division of Child Neurology

University of Kentucky

Wednesday, August 12, 2026

8:00 - 9:00 AM EDT

Zoom only: https://uky.zoom.us/j/89948846670

After this session, participants will be able to:

1. Discuss the unique features of pediatric onset multiple sclerosis as compared to adult onset
2. Identify potential treatment options for pediatric onset multiple sclerosis
3. Compare the potential benefits of early high efficacy therapy versus escalation therapy

Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Kaitlyn Cartwright, MD, faculty for this educational event, has been a Co-Investigator in clinical trials sponsored by Immunic Therapeutics, Sanofi, and Zenas BioPharma.

All of the relevant financial relationships listed for this individual have been mitigated.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.